Valproate and neuroprotective effects for bipolar disorder

International Review of Psychiatry

Volumn 21, Issue 4, 2009, Pages 410-413

  Atmaca, Murad ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HISTONE DEACETYLASE; LITHIUM; N ACETYLASPARTIC ACID; QUETIAPINE; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR AP 1; VALPROATE SEMISODIUM; VALPROIC ACID;

APOPTOSIS; BIPOLAR DISORDER; BIPOLAR MANIA; BRAIN; BRAIN CELL; CELL FUNCTION; CELL STRAIN; CELL VIABILITY; CINGULATE GYRUS; DENTATE GYRUS; DEPRESSION; DNA BINDING; DRUG STRUCTURE; ENDOPLASMIC RETICULUM; EXCITOTOXICITY; GENE EXPRESSION; GLIOMA CELL; GRANULE CELL; HIPPOCAMPUS; HUMAN; LONG TERM CARE; MENTAL DISEASE; MONOTHERAPY; MOOD DISORDER; NERVE CELL; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY;

ANIMALS; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; GENE EXPRESSION; HUMANS; LITHIUM CARBONATE; NERVE NET; NEURONS; NEUROPROTECTIVE AGENTS; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 70350639622     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260902962206     Document Type: Short Survey

References (45)

1. Asghari, V., Wang, J.F., Reiach, J.S., & Young, L.T. (1999). Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY- 5Y cells. Molecular Brain Research, 58, 95-102.
2. Atmaca, M., Yildirim, H., Ozdemir, H., Ogur, E., & Tezcan, E. (2007). Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychological Medicine, 37, 121-129.
3. Atmaca, M., Ozdemir, H., Cetinkaya, S., Parmaksiz, S., Belli, H., Poyraz, K. et al. (2007). Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine. Journal of Psychiatric Research, 41, 821-827.
4. Baxter, L.R., Schwartz, J.M., Phelps, M.E., Mazziotta, J.C., Guze, B.H., Selin, C.E. et al. (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry, 46, 243-250.
5. Bertolino, A., Frye, M., Callicott, J.H., Mattay, V.S., Rakow, R., Shelton-Repella, J. et al. (2003). Neuronal pathology in the hippocampal area of patients with bipolar disorder:A study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry, 53, 906-913.
6. Bowden, C.L. (1996). Dosing strategies and time course of response to antimanic drugs. Journal of Clinical Psychiatry, 57(Suppl.13), 4-9.
7. Bown, C.D., Wang, J.F., Chen, B., & Young, L.T. (2002). Regulation of ER stress proteins by valproate: Therapeutic implications. Bipolar Disorders, 4, 145-151.
8. Bown, C.D., Wang, J.F., Chen, B., & Young, L.T. (2002). Regulation of ER stress proteins by valproate: Therapeutic implications. Bipolar Disorders, 4, 145-151.
9. Cendes, F., Andermann, F., Dubeau, F., Matthews, P.M., & Arnold, D.L. (1997). Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology, 49, 1525-1533.
10. Chang, K.D., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A., & Ketter, T. (2003). Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry, 53, 1059-1065.
11. Chen, G., Hasanat, K.A., Bebchuk, J.M., Moore, G.J., Glitz, D., & Manji, H.K. (1999). Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosomatic Medicine, 61, 599-617. (Pubitemid 29455084)
12. Chen, G., Zeng, W.Z., Yuan, P.X., Huang, L.D., Jiang, Y.M., Zhao, Z.H. et al. (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry, 72, 879-882.
13. Chuang, D.M. (2005). The antiapoptotic actions of mood stabilizers: Molecular mechanisms and therapeutic potentials. Annals of the NewYork Academy of Science, 1053, 195-204.
14. Cui, J., Shao, L., Young, L.T., & Wang, J.F. (2007). Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience, 144, 1447-1453.
15. Dando, T.M., & Keating, G.M. (2005). Quetiapine: A review of its use in acute mania and depression associated with bipolar disorder. Drugs, 65, 2533-2551.
16. De Sarno, P., Li, X., & Jope, R.S. (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology, 43, 1158-1164.
17. Deicken, R.F., Pegues, M.P., Anzalone, S., Feiwell, R., & Soher, B. (2003). Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. American Journal of Psychiatry, 160, 873-882.
18. Drevets, W.C. (1999). Prefrontal cortical-amygdalar metabolism in major depression. Annals of New York Academy of Science, 877, 614-637.
19. Drevets, W.C. (2000). Neuroimaging studies of mood disorders. Biological Psychiatry, 48, 813-829.
20. Dringen, R., & Hirrlinger, J. (2003). Glutathione pathways in the brain. Biological Chemistry, 384, 505-516.
21. Fukumoto, T., Morinobu, S., Okamoto, Y., Kagay, A., & Yamawaki, S. (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology, 158, 100-106.
22. Gao, K., & Calabrese, J.R. (2005). Newer treatment studies for bipolar depression. Bipolar Disord, 7, 13-23.
23. Gottlicher, M., Minucc, S., Zhu, P., Kramer, O.H., Schimpf, A., Giavara, S. et al. (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO Journal, 20, 6969-6978.
24. Hamakawa, H., Kato, T., Shioiri, T., Inubushi, T., & Kato, N. (1999). Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychological Medicine, 29, 639-644.
25. Hao, Y., Creson, T., Zhang, L., Li, P., Du, F., Yuan, P. et al. (2004). Mood stabilizer valproate promotes ERK pathwaydependent cortical neuronal growth and neurogenesis. Journal of Neuroscience, 24, 6590-6599.
26. Hiroi, T., Wei, H., Hough, C., Leeds, P., & Chuang, D.-M. (2005). Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: Roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics Journal, 5, 102-111.
27. Hyman, S.E., & Nestler, E.J. (1996). Initiation and adaptation: A paradigm for understanding psychotropic drug action. American Journal of Psychiatry, 153, 151-162.
28. Jenkins, B.G., Klivenyi, P., Kustermann, E., Andreassen, O.A., Ferrante, R.J., Rosen, B.R. et al. (2000). Non-linear decrease over time in N-acetylaspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. Journal of Neurochemistry, 74, 2108-2119.
29. Kanai, H., Sawa, A., Chen, R.W., Leeds, P., & Chuang, D.M. (2004). Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics Journal, 4, 336-344.
30. Lenox, R.H., Mcnamara, R.K., Papke, R.L., & Manji, H.K. (1998). Neurobiology of lithium: An update. Journal of Clinical Psychiatry, 59(Suppl.6), S37-S47.
31. Manji, H.K., Potter, W.Z., & Lenox, R.H. (1995). Signal transduction pathways: Molecular targets for lithium's action. Archives of General Psychiatry, 52, 531-543.
32. McElroy, S.L., Keck Jr, P.E., Pope Jr, H.G., & Hudson, J.I. (1992). Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. Journal of Clinical Psychopharmacology, 12(Suppl.), S42-S51.
33. Moffett, J.R., & Namboodiri, M.A. (1995). Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. Journal of Neurocytology, 24, 409-433.
34. Moore, G.J., Bebchuk, J.M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I.B. et al. (2000). Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of Bcl-2's neurotrophic effects? Biological Psychiatry, 48, 1-8.
35. Ozaki, N., & Chuang, D.M. (1997). Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. Journal of Neurochemistry, 69, 2336-2344.
36. Petroff, O.A., Errante, L.D., Rothman, D.L., Kim, J.H., & Spencer, D.D. (2002). Neuronal and glial metabolite content of the epileptogenic human hippocampus. Annals of Neurology, 52, 635-642.
37. Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G, Lazar, M.A., & Klein, P.S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biologcal Chemistry, 276, 36734-36741.
38. Post, R.M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry, 149, 999-1010.
39. Rajkowska, G., Halaris, D., & Selemon, L.D. (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry, 49, 741-752.
40. Ren, M., Leng, Y., Jeong, M., Leeds, P.R., & Chuang, D.M. (2004). Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: Potential roles of histone deacetylase inhibition and heat shock protein induction. Journal of Neurochemistry, 89, 1358-1367.
41. Richards, T.L. (1991). Proton MR spectroscopy in multiple sclerosis: Value in establishing diagnosis, monitoring progression and evaluating therapy. American Journal of Radiolog, 157, 1073-1078.
42. Urenjak, J., Williams, S.R., Gadian, D.G., & Noble, M. (1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience, 13, 981-989.
43. Wang, J.F., Bown, C., & Young, L.T. (1999). Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78. Molecular Pharmacology, 55, 521-527.
44. Winsberg, M.E., Sachs, N., Tate, D.L., Adalsteinsson, E., Spielman, D., & Ketter, T.A. (2000). Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biological Psychiatry, 47, 475-481.
45. Yuan, P.X., Huang, L.D., Jiang, Y.M., Gutkind, J.S., Manji, H.K., & Chen, G. (2001). The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry, 276, 31674-31683.